Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data LM Hock, J Lynch, KC Balaji The Journal of urology 167 (1), 57-60, 2002 | 524 | 2002 |
Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis C Maramag, M Menon, KC Balaji, PG Reddy, S Laxmanan The Prostate 32 (3), 188-195, 1997 | 203 | 1997 |
Mechanism of stone formation KC Balaji, M Menon Urologic Clinics of North America 24 (1), 1-11, 1997 | 192 | 1997 |
Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail C Du, C Zhang, S Hassan, MHU Biswas, KC Balaji Cancer research 70 (20), 7810-7819, 2010 | 180 | 2010 |
E-cadherin phosphorylation by protein kinase D1/protein kinase Cμ is associated with altered cellular aggregation and motility in prostate cancer M Jaggi, PS Rao, DJ Smith, MJ Wheelock, KR Johnson, GP Hemstreet, ... Cancer research 65 (2), 483-492, 2005 | 179 | 2005 |
Feasibility of robot-assisted totally intracorporeal laparoscopic ileal conduit urinary diversion: initial results of a single institutional pilot study KC Balaji, P Yohannes, CL McBride, D Oleynikov, GP Hemstreet III Urology 63 (1), 51-55, 2004 | 151 | 2004 |
N‐cadherin switching occurs in high Gleason grade prostate cancer M Jaggi, T Nazemi, NA Abrahams, JJ Baker, A Galich, LM Smith, ... The Prostate 66 (2), 193-199, 2006 | 147 | 2006 |
Aberrant expression of E-cadherin and beta-catenin in human prostate cancer☆ M Jaggi, SL Johansson, JJ Baker, LM Smith, A Galich, KC Balaji Urologic Oncology: Seminars and Original Investigations 23 (6), 402-406, 2005 | 146 | 2005 |
Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas Z Jiang, PG Chu, BA Woda, Q Liu, KC Balaji, KL Rock, CL Wu Clinical cancer research 14 (17), 5579-5584, 2008 | 109 | 2008 |
Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation KC Balaji, M McGUIRE, J GROTAS, G GRIMALDI, P RUSSO The Journal of urology 162 (5), 1603-1606, 1999 | 109 | 1999 |
Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy LS Krane, KA Richards, AK Kader, R Davis, KC Balaji, AK Hemal Journal of endourology 27 (8), 1046-1050, 2013 | 104 | 2013 |
Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone S Sharma, F Xing, Y Liu, K Wu, N Said, R Pochampally, Y Shiozawa, ... Journal of Biological Chemistry 291 (37), 19351-19363, 2016 | 101 | 2016 |
Feasibility of robotic radical nephrectomy—initial results of single-institution pilot study DW Klingler, GP Hemstreet, KC Balaji Urology 65 (6), 1086-1089, 2005 | 99 | 2005 |
Protein kinase C μ is down-regulated in androgen-independent prostate cancer M Jaggi, PS Rao, DJ Smith, GP Hemstreet, KC Balaji Biochemical and Biophysical Research Communications 307 (2), 254-260, 2003 | 95 | 2003 |
Protein kinase D1–mediated phosphorylation and subcellular localization of β-catenin C Du, M Jaggi, C Zhang, KC Balaji Cancer research 69 (3), 1117-1124, 2009 | 93 | 2009 |
Comparative analysis of early perioperative outcomes following radical cystectomy by either the robotic or open method A Galich, S Sterrett, T Nazemi, G Pohlman, L Smith, KC Balaji JSLS: Journal of the Society of Laparoendoscopic Surgeons 10 (2), 145, 2006 | 92 | 2006 |
Splenogonadal fusion: case presentation and literature review MK Abou Bakr, AM Ismail Journal of pediatric surgery 40 (8), 1357-1360, 2005 | 82 | 2005 |
Radical nephrectomy performed by open, laparoscopy with or without hand-assistance or robotic methods by the same surgeon produces comparable perioperative results T Nazemi, A Galich, S Sterrett, D Klingler, L Smith, KC Balaji International braz j urol 32, 15-22, 2006 | 78 | 2006 |
Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer KC Balaji, H Koul, S Mitra, C Maramag, P Reddy, M Menon, RK Malhotra, ... Urology 50 (6), 1007-1015, 1997 | 78 | 1997 |
Metallothioneins and resistance to cisplatin and radiation in prostate cancer DJ Smith, M Jaggi, W Zhang, A Galich, C Du, SP Sterrett, LM Smith, ... Urology 67 (6), 1341-1347, 2006 | 75 | 2006 |